Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes -: Nuclear factor-κB activation by TNF-α is obligatory

被引:403
作者
Ruan, H
Hacohen, N
Golub, TR
Van Parijs, L
Lodish, HF
机构
[1] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[4] MIT, Dept Biol, Cambridge, MA 02142 USA
[5] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
关键词
D O I
10.2337/diabetes.51.5.1319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) is a contributing cause of the insulin resistance seen in obesity and obesity-linked type 2 diabetes, but the mechanism(s) by which TNF-alpha induces Insulin resistance is not understood. By using 3T3-L1 adipocytes and oligonucleotide microarrays, we identified 142 known genes reproducibly upregulated by at least threefold after 4 h and/or 24 It of TNF-alpha treatment, and 78 known genes down-regulated by at least twofold after 24 h of TNF-alpha incubation. TNF-alpha-induced genes include transcription factors implicated in preadipocyte gene expression or NF-kappaB activation, cytokines and cytokine-induced proteins, growth factors, enzymes, and signaling molecules. Importantly, a number of adipocyte-abundant genes, including GLUT4, hormone sensitive lipase, long-chain fatty acyl-CoA synthase, adipocyte complement-related protein of 30 kDa, and transcription factors CCAAT/ enhancer binding protein-alpha, receptor retinoid X receptor-alpha, and peroxisome profilerator-activated receptor gamma were significantly downregulated by TNF-alpha treatment. Correspondingly, 24-h exposure of 3T3-L1 adipocytes to TNF-alpha resulted in reduced protein levels of GLUT4 and several insulin signaling proteins, including the insulin receptor, insulin receptor substrate 1 (IRS-1), and protein kinase B (AKT). Nuclear factor-kappaB (NF-kappaB) was activated within 15 min of TNF-alpha addition. 3T3-L1 adipocytes expressing IkappaBalpha-DN, a nondegradable NF-kappaB inhibitor, exhibited normal morphology, global gene expression, and insulin responses. However, absence of NF-kappaB activation abolished suppression of >98% of the genes normally suppressed by TNF-alpha and induction of 60-70% of the genes normally induced by TNF-alpha. Moreover, extensive cell death occurred in IkappaBalpha-DN-expressing adipocytes after 2 h of TNF-alpha treatment. Thus the changes in adipocyte gene expression induced by TNF-alpha could lead to insulin resistance. Farther, NF-kappaB is an obligatory mediator of most of these TNF-alpha responses.
引用
收藏
页码:1319 / 1336
页数:18
相关论文
共 53 条
  • [1] NF-kappa B: Ten years after
    Baeuerle, PA
    Baltimore, D
    [J]. CELL, 1996, 87 (01) : 13 - 20
  • [2] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [3] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [4] MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE
    BODEN, G
    CHEN, XH
    RUIZ, J
    WHITE, JV
    ROSSETTI, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2438 - 2446
  • [5] ALTERED IMMUNE FUNCTION IN A MORBIDLY OBESE PEDIATRIC POPULATION
    BOECK, MA
    CHEN, C
    CUNNINGHAMRUNDLES, S
    [J]. PREVENTION AND TREATMENT OF CHILDHOOD OBESITY, 1993, 699 : 253 - 256
  • [6] CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION
    BROWN, K
    GERSTBERGER, S
    CARLSON, L
    FRANZOSO, G
    SIEBENLIST, U
    [J]. SCIENCE, 1995, 267 (5203) : 1485 - 1488
  • [7] NF-κB activation by tumor necrosis factor and interleukin-1
    Cao, Z
    Tanaka, M
    Regnier, C
    Rothe, M
    Yamit-Hezi, A
    Woronicz, JD
    Fuentes, ME
    Durnin, MH
    Dalrymple, SA
    Goeddel, DV
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 473 - 483
  • [8] Endocrine and metabolic effects of interferon-alpha in humans
    Corssmit, EPM
    Heijligenberg, R
    Endert, E
    Ackermans, MT
    Sauerwein, HP
    Romijn, JA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) : 3265 - 3269
  • [9] REDUCED GLYCOGEN-SYNTHASE ACTIVITY IN SKELETAL-MUSCLE FROM OBESE PATIENTS WITH AND WITHOUT TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    DAMSBO, P
    VAAG, A
    HOTHERNIELSEN, O
    BECKNIELSEN, H
    [J]. DIABETOLOGIA, 1991, 34 (04) : 239 - 245
  • [10] The IκB kinase:: A master regulator of NF-κB, innate immunity, and epidermal differentiation
    Delhase, M
    Karin, M
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 491 - 503